Age is a major modifier of inflammatory CSF signatures in MS. This finding identifies novel biomarker candidates and potential therapeutic targets.
A groundbreaking study published in BMC Nephrology found that metabolic dysfunction associated fatty liver disease (MAFLD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback